Alpine-Bio ApS: Financial statements 2025
CVR: 44607379
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Alpine-Bio ApS (CVR 44607379) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 179,268 and a net result of DKK -61,697 compared with DKK -156,738 the year before. That is an increase of 88.9% compared with the year before. Equity in the 2025 report amounted to DKK 621,565. The solvency ratio was 18.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 179,268
- Profit/Loss
- DKK -61,697
- Equity
- DKK 621,565
- Total Assets
- DKK 3,293,166
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 179 t. | -62 t. | 622 t. | 1 |
| 2024 | - | 95 t. | -157 t. | 383 t. | 1 |
Official annual report
How creditworthy is Alpine-Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 2, 2025, S21 Holding ApS is registered as an owner of Alpine-Bio ApS with an ownership share of 20%.
Alpine-Bio ApS has published its annual report for 2024. Gross profit came to DKK 94,889, and the net result was DKK -156,738.
As of April 14, 2025, JUUZ ApS is registered as an owner of Alpine-Bio ApS with an ownership share of 66%.
About Alpine-Bio ApS
Alpine-Bio ApS is a Danish company of the type Anpartsselskab based in Albertslund, founded in 2024. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Søren Anker Nielsen. The company is owned by JUUZ ApS and S21 Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 179,268 and a net result of DKK -61,697 compared with DKK -156,738 the year before. Equity in the 2025 report amounted to DKK 621,565.